13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q4 2024 · Filed January 28, 2025 · Accession 0001104659-25-006699
Total Value
$51.1M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $19.9M | 38.83% |
| 2 | TOURMALINE BIO INC | 89157D105 | 741,691 | $15.0M | 29.41% |
| 3 | KORRO BIO INC | KRRO | 368,085 | $14.0M | 27.40% |
| 4 | VENTYX BIOSCIENCES INC | 92332V107 | 412,225 | $902,773 | 1.77% |
| 5 | HILLEVAX INC | 43157M102 | 372,615 | $771,313 | 1.51% |
| 6 | KEZAR LIFE SCIENCES INC | KZR | 82,871 | $556,893 | 1.09% |